Analysts Set Avantor, Inc. (NYSE:AVTR) PT at $14.42

Avantor, Inc. (NYSE:AVTR) has received a consensus rating of “Hold” from the fifteen brokerages that are covering the stock, Marketbeat Ratings reports. Eleven investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $14.4231.

Several analysts have issued reports on the stock. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $12.00 price objective (down previously from $14.00) on shares of Avantor in a research note on Thursday, October 30th. Stifel Nicolaus set a $12.00 price target on Avantor and gave the stock a “hold” rating in a research note on Monday, August 4th. Robert W. Baird upped their price objective on Avantor from $15.00 to $17.00 and gave the company an “outperform” rating in a research report on Friday, October 24th. Jefferies Financial Group reiterated a “hold” rating on shares of Avantor in a research report on Friday, August 1st. Finally, Morgan Stanley lowered their target price on shares of Avantor from $15.00 to $12.00 and set an “equal weight” rating for the company in a research note on Monday, August 4th.

Avantor Stock Up 2.7%

Shares of AVTR opened at $11.18 on Friday. The company has a quick ratio of 0.96, a current ratio of 1.49 and a debt-to-equity ratio of 0.65. The business has a fifty day moving average of $12.91 and a 200 day moving average of $13.02. The company has a market cap of $7.62 billion, a PE ratio of -85.96, a P/E/G ratio of 3.75 and a beta of 1.00. Avantor has a 52-week low of $10.82 and a 52-week high of $23.32.

Avantor (NYSE:AVTR) last announced its earnings results on Wednesday, October 29th. The company reported $0.22 earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.01). Avantor had a negative net margin of 1.25% and a positive return on equity of 10.91%. The firm had revenue of $1.62 billion during the quarter, compared to analysts’ expectations of $1.65 billion. During the same period in the prior year, the company posted $0.26 EPS. The company’s revenue was down 5.3% compared to the same quarter last year. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. On average, sell-side analysts expect that Avantor will post 1.06 EPS for the current year.

Insider Buying and Selling

In related news, Director Gregory L. Summe bought 100,000 shares of the company’s stock in a transaction on Thursday, October 30th. The shares were acquired at an average cost of $11.25 per share, for a total transaction of $1,125,000.00. Following the purchase, the director directly owned 300,000 shares of the company’s stock, valued at approximately $3,375,000. The trade was a 50.00% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.20% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Rise Advisors LLC purchased a new stake in shares of Avantor in the 1st quarter worth $25,000. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Avantor by 288.4% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 1,701 shares of the company’s stock valued at $28,000 after acquiring an additional 1,263 shares in the last quarter. Wealthquest Corp purchased a new stake in Avantor in the first quarter worth about $34,000. EverSource Wealth Advisors LLC grew its holdings in Avantor by 119.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after acquiring an additional 1,189 shares in the last quarter. Finally, Strategic Wealth Investment Group LLC purchased a new position in Avantor during the 2nd quarter valued at about $32,000. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.